ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 78.54% of BMY shares are held by financial institutions. is the top corporate investor, holding 7.27M shares valued at $392.61M. A 0.36% stake in Bristol-Myers Squibb Company is owned by the company. UBS ASSET MANAGEMENT AMERICAS INC owns 12.2M shares valued at $661.34M, which translates its holding of 0.6% of the stake in the company.
Among the BMY insiders holding of 0.11% of the stake in company, CELGENE CORP /DE/, 10 percent owner, holds the largest shares of 7.01M. ANDREOTTI LAMBERTO, director, is the second largest BMY insider with ownership of 935.57K shares. LEUNG SANDRA, EVP, General Counsel, stands third with possession of 308.63K shares of that stake.